CHAMPIONS ONCOLOGY, INC. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 0 shares for the 12-month period ending 2026-04-30, per its 10-K filed 2026-07-27.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2026-07-27
- CHAMPIONS ONCOLOGY, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2026-01-31 was 0.00 shares, a 100.00% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2025-10-31 was 665.92K shares, a 57.36% increase year-over-year.
- CHAMPIONS ONCOLOGY, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2025-07-31 was 0.00 shares, a 100.00% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2025-01-31 was 664.28K shares.
- CHAMPIONS ONCOLOGY, INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2026 was 0.00 shares, a 100.00% decline from fiscal 2025.
- CHAMPIONS ONCOLOGY, INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2025 was 607.00K shares.
- CHAMPIONS ONCOLOGY, INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2024 was 0.00 shares.
- CHAMPIONS ONCOLOGY, INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2023 was 0.00 shares, a 100.00% decline from fiscal 2022.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month as first filed |
|---|---|---|---|---|---|
| 2026-04-30 | 0.00 shares 10-K · filed 2026-07-27 | ||||
| 2026-01-31 | 0.00 shares 10-Q · filed 2026-03-12 | 0.00 shares 10-Q · filed 2026-03-12 | |||
| 2025-10-31 | 665.92K shares 10-Q · filed 2025-12-15 | 0.00 shares 10-Q · filed 2025-12-15 | |||
| 2025-07-31 | 0.00 shares 10-Q · filed 2025-09-15 | ||||
| 2025-04-30 | 607.00K shares 10-K · filed 2026-07-27 | ||||
| 2025-01-31 | 664.28K shares 10-Q · filed 2026-03-12 | 512.03K shares 10-Q · filed 2026-03-12 | |||
| 2024-10-31 | 423.19K shares 10-Q · filed 2025-12-15 | 435.90K shares 10-Q · filed 2025-12-15 | |||
| 2024-07-31 | 448.61K shares 10-Q · filed 2025-09-15 | ||||
| 2024-04-30 | 0.00 shares 10-K · filed 2025-07-23 | ||||
| 2024-01-31 | 0.00 shares 10-Q · filed 2025-03-17 | 0.00 shares 10-Q · filed 2025-03-17 | |||
| 2023-10-31 | 0.00 shares 10-Q · filed 2024-12-16 | 0.00 shares 10-Q · filed 2024-12-16 | |||
| 2023-07-31 | 0.00 shares 10-Q · filed 2024-09-13 | ||||
| 2023-04-30 | 0.00 shares 10-K · filed 2023-07-24 | ||||
| 2023-01-31 | 0.00 shares 10-Q · filed 2023-03-16 | 0.00 shares 10-Q · filed 2023-03-16 | |||
| 2022-04-30 | 962.63K shares 10-K · filed 2023-07-24 | ||||
| 2022-01-31 | 886.57K shares 10-Q · filed 2023-03-16 | 1.01M shares 10-Q · filed 2023-03-16 | |||
| 2021-10-31 | 1.12M shares 10-Q · filed 2021-12-13 | 1.07M shares 10-Q · filed 2021-12-13 | |||
| 2021-07-31 | 0.00 shares 10-Q · filed 2021-09-13 | ||||
| 2021-04-30 | 1.43M shares 10-K · filed 2022-07-22 | ||||
| 2021-01-31 | 1.14M shares 10-Q · filed 2022-03-15 | 1.54M shares 10-Q · filed 2022-03-15 | |||
| 2020-10-31 | 2.00M shares 10-Q · filed 2021-12-13 | 1.75M shares 10-Q · filed 2021-12-13 | |||
| 2020-07-31 | 1.50M shares 10-Q · filed 2021-09-13 | ||||
| 2020-04-30 | 0.00 shares 10-K · filed 2021-07-26 | ||||
| 2020-01-31 | 1.92M shares 10-Q · filed 2021-03-15 | 1.79M shares 10-Q · filed 2021-03-15 | |||
| 2019-10-31 | 1.35M shares 10-Q · filed 2020-12-14 | 0.00 shares 10-Q · filed 2020-12-14 | |||
| 2019-07-31 | 0.00 shares 10-Q · filed 2020-09-14 | ||||
| 2019-04-30 | 2.76M shares 10-K · filed 2020-07-28 | ||||
| 2019-01-31 | 0.00 shares 10-Q · filed 2020-03-16 | 2.65M shares 10-Q · filed 2020-03-16 | |||
| 2018-10-31 | 2.76M shares 10-Q · filed 2019-12-16 | 2.36M shares 10-Q · filed 2019-12-16 | |||
| 2018-07-31 | 1.61M shares 10-Q · filed 2019-09-16 | ||||
| 2018-04-30 | 0.00 shares 10-K · filed 2019-07-29 | ||||
| 2018-01-31 | 0.00 shares 10-Q · filed 2019-03-18 | 0.00 shares 10-Q · filed 2019-03-18 | |||
| 2017-10-31 | 0.00 shares 10-Q · filed 2018-12-17 | 0.00 shares 10-Q · filed 2018-12-17 | |||
| 2017-07-31 | 0.00 shares 10-Q · filed 2018-09-14 | ||||
| 2016-04-30 | 0.00 shares 10-K · filed 2016-07-29 | ||||
| 2016-01-31 | 0.00 shares 10-Q · filed 2016-03-16 | 0.00 shares 10-Q · filed 2016-03-16 | |||
| 2015-10-31 | 0.00 shares 10-Q · filed 2015-12-15 | 0.00 shares 10-Q · filed 2015-12-15 | |||
| 2015-07-31 | 0.00 shares 10-Q · filed 2015-09-11 | ||||
| 2015-04-30 | 439.06K shares 10-K · filed 2016-07-29 | 5.27M shares 10-K · filed 2015-07-29 | |||
| 2015-01-31 | 29.35K shares 10-Q · filed 2016-03-16 | 29.35K shares 10-Q · filed 2016-03-16 | |||
| 2014-10-31 | 80.67K shares 10-Q · filed 2015-12-15 | 80.67K shares 10-Q · filed 2015-12-15 | |||
| 2014-07-31 | 245.74K shares 10-Q · filed 2015-09-11 | ||||
| 2014-04-30 | 0.00 shares 10-K · filed 2015-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |